SAUDI ARABIA

Saudi Drug Authority, China’s National Medical Products Administration sign MoU for regulatory collaboration

November 01, 2024
The agreement was signed in Beijing.
The agreement was signed in Beijing.

BEIJING — The Saudi Food and Drug Authority (SFDA) signed a Memorandum of Understanding (MoU) on Friday with China’s National Medical Products Administration (NMPA) in Beijing, aiming to enhance cooperation in regulatory matters.

The agreement was signed by SFDA's CEO Dr. Hisham Aljadhey and NMPA Commissioner Li Li, with Saudi Arabia’s Ambassador to China, Abdulrahman Al-Harbi, in attendance.

The MoU focuses on sharing regulatory information related to medicines, medical devices, and cosmetics, covering laws, regulations, and best practices. This partnership highlights the SFDA’s commitment to bolstering international cooperation through strategic alliances.

This agreement coincides with Dr. Aljadhey’s visit to China, where he will lead the Saudi delegation at the 8th Shenzhen Food Safety Forum, scheduled for November 5-6, 2024. — SG


November 01, 2024
205 views
HIGHLIGHTS
SAUDI ARABIA
12 hours ago

Al-Bassami: Pilgrims’ safety is a cornerstone of Interior Ministry’s security planning

SAUDI ARABIA
12 hours ago

134 endangered species released into NEOM Nature Reserve

SAUDI ARABIA
16 hours ago

Saudi Arabia signs mining deals with 6 countries